Observations on sexually transmitted diseases in promiscuous males in Djibouti. NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Observations on sexually transmitted diseases in promiscuous males in Djibouti.

J Egypt Public Health Assoc. 1989;64(5-6):561-9. Unique Identifier : AIDSLINE MED/92166667
Fox E; Haberberger RL Jr; Abbatte EA; Said-Salah; Polycarpe D; Constantine NT

Abstract: Observations are reported on 7 sexually transmitted diseases in a heterosexual population of 105 promiscuous males in Djibouti, East Africa. Neisseria gonorrhoeae was cultured from urethral swabs from 34 subjects. Six isolates were beta lactamase positive (18%). High levels of resistance to antimicrobials were noted with penicillin, spectinomycin and cotrimoxazole, while tetracyclines and erythromycin were unvariably effective. Six patients had Chlamydia urethritis, one of whom had concomitant gonococcal urethritis. Half of the sera reacted positive for antibodies to Chlamydia. A total of 31 subjects had a positive treponemal FTA-Abs test; of these, only 14 had a reactive RPR test. Nineteen individuals were positive for HBsAg. One subject had a western blot confirmed HIV-1 infection, while none had antibodies to HIV-2 or HTLV-I.
Keywords: Adolescence Adult AIDS Serodiagnosis Chlamydia trachomatis/ISOLATION & PURIF Djibouti/EPIDEMIOLOGY Human Male Neisseria gonorrhoeae/ISOLATION & PURIF *Sex Behavior Sexually Transmitted Diseases/*EPIDEMIOLOGY/MICROBIOLOGY Support, U.S. Gov't, Non-P.H.S. JOURNAL ARTICLEKWDadolescenceadultaidsserodiagnosischlamydiatrachomatis/isolation&purifdjibouti/epidemiologyhumanmaleneisseriagonorrhoeae/isolation&purifKWDsexbehaviorsexuallytransmitteddiseases/KWDepidemiology/microbiologysupport,uKWDsKWDgov't,non-pKWDhKWDsKWDjournalarticle
920630
M9261000

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .